CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination

References

• Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998; 392 6676: 565–568.
   PubMed Web of Science ®Google Scholar
• Luster AD. Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med. 1998; 338 7: 436–445.
   PubMed Web of Science ®Google Scholar
• Thelen M. Dancing to the tune of chemokines. Nat Immunol. 2001; 2 2: 129–134.
   PubMed Web of Science ®Google Scholar
• Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002; 168 7: 3195–3204.
   PubMed Web of Science ®Google Scholar
• Glass WG, Lane TE. Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+T cells following coronavirus infection of the central nervous system. Virology. 2003; 312 2: 407–414.
   PubMed Web of Science ®Google Scholar
• Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med. 2005; 202 8: 1087–1098.
   PubMed Web of Science ®Google Scholar
• Liu MT, Armstrong D, Hamilton TA, Lane TE. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol. 2001; 166 3: 1790–1795.
   PubMed Web of Science ®Google Scholar
• Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol. 2000; 165 5: 2327–2330.
   PubMed Web of Science ®Google Scholar
• Liu MT, Keirstead HS, Lane TE. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol. 2001; 167 7: 4091–4097.
   PubMedGoogle Scholar
• Trifilo MJ, Bergmann CC, Kuziel WA, Lane TE. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J Virol. 2003; 77 7: 4004–4014.
   PubMed Web of Science ®Google Scholar
• Stiles LN, Hosking MP, Edwards RA, Strieter RM, Lane TE. Differential roles for CXCR3 in CD4+ and CD8+T cell trafficking following viral infection of the CNS. Eur J Immunol. 2006; 36 3: 613–622.
   PubMed Web of Science ®Google Scholar
• Holmes K, Lai MFields virologyFields virologyB.N. FieldsD.M. KnipeP.M. HowelyLippincott-Raven PublishersPhiladelphia, PA19961075–1094.
   Google Scholar
• McIntosh KFields virologyFields virologyB.N. FieldsD.M. KnipeP.M. HowelyLippincott-Raven PublishersPhiladelphia, PA1996401–430.
   Google Scholar
• Marten NW, Stohlman SA, Bergmann CC. MHV infection of the CNS: Mechanisms of immune-mediated control. Viral Immunol. 2001; 14 1: 1–18.
   PubMed Web of Science ®Google Scholar
• Bergmann CC, Yao Q, Lin M, Stohlman SA. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J Gen Virol. 1996; 77 Pt 2: 315–325.
   PubMedGoogle Scholar
• Castro RF, Perlman S. CD8+T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol. 1995; 69 12: 8127–8131.
   PubMedGoogle Scholar
• Xue S, Jaszewski A, Perlman S. Identification of a CD4+T cell epitope within the M protein of a neurotropic coronavirus. Virology. 1995; 208 1: 173–179.
   PubMed Web of Science ®Google Scholar
• Houtman JJ, Fleming JO. Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol. 1996; 2 6: 361–376.
   PubMed Web of Science ®Google Scholar
• Lin MT, Stohlman SA, Hinton DR. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol. 1997; 71 1: 383–391.
   PubMed Web of Science ®Google Scholar
• Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol. 1999; 162 3: 1641–1647.
   PubMed Web of Science ®Google Scholar
• Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol. 2000; 74 3: 1415–1424.
   PubMed Web of Science ®Google Scholar
• Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol. 2000; 165 4: 2278–2286.
   PubMed Web of Science ®Google Scholar
• Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM, Hamilton TA. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol. 1998; 161 2: 927–932.
   PubMed Web of Science ®Google Scholar
• Stiles LN, Hardison JL, Schaumburg CS, Whitman LM, Lane TE. T cell anti-viral effector function is not dependent on CXCL10 following murine coronavirus infection. J Immunol. 2006; 177 12: 8372–8380.
   PubMed Web of Science ®Google Scholar
• Chen BP, Kuziel WA, Lane TE. Lack of CCR2 results in increased mortality and impaired leukocyte activation and trafficking following infection of the central nervous system with a neurotropic coronavirus. J Immunol. 2001; 167 8: 4585–4592.
   PubMed Web of Science ®Google Scholar
• Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996; 184 3: 963–969.
   PubMed Web of Science ®Google Scholar
• Loetscher M, Loetscher P, Brass N, Meese E, Moser B. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization. Eur J Immunol. 1998; 28 11: 3696–3705.
   PubMed Web of Science ®Google Scholar
• Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol. 2004; 172 7: 4018–4025.
   PubMed Web of Science ®Google Scholar
• Glass WG, Liu MT, Kuziel WA, Lane TE. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology. 2001; 288 1: 8–17.
   PubMed Web of Science ®Google Scholar
• Held KS, Chen BP, Kuziel WA, Rollins BJ, Lane TE. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology. 2004; 329 2: 251–260.
   PubMed Web of Science ®Google Scholar
• Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol. 1998; 160 2: 970–978.
   PubMed Web of Science ®Google Scholar
• Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. Neuronal CXCL10 directs CD8+T-cell recruitment and control of West Nile virus encephalitis. J Virol. 2005; 79 17: 11457–11466.
   PubMed Web of Science ®Google Scholar
• Marten NW, Stohlman SA, Bergmann CC. Role of viral persistence in retaining CD8(+) T cells within the central nervous system. J Virol. 2000; 74 17: 7903–7910.
   PubMedGoogle Scholar